Deep brain stimulation—A new treatment approach in patients with multiple sclerosis

February 8, 2018, Charité - Universitätsmedizin Berlin

A pilot study conducted by researchers from Charité's NeuroCure Cluster of Excellence has shown that treatment with deep transcranial magnetic stimulation (dTMS) significantly reduces symptoms of fatigue in patients with multiple sclerosis (MS). Published in the current issue of the journal Neurology: Neuroimmunology & Neuroinflammation, results from this research suggest that TMS is a safe option for the treatment of patients with MS.

Up to 90 percent of people living with MS report experiencing severe fatigue. Fatigue can have a serious impact on both a person's work and social life, and leads many to give up work. In fact, a large percentage of people with MS rate fatigue as one of the most bothersome symptoms of the disease. Treatment options are scarce, and no licensed pharmaceutical treatments are available. In contrast, dTMS has been used in the diagnosis and of a range of neurological and psychiatric disorders.

A team of researchers led by Prof. Dr. Friedemann Paul of the NeuroCure Clinical Research Center (NCRC) has shown that dTMS, using the proprietary H-coil, a technology that allows brain stimulation three times deeper than that of standard TMS, is capable of producing significant improvements in fatigue symptoms. The severity of MS-associated symptoms was assessed using a standardized questionnaire and the Fatigue Severity Scale (FSS). 33 study participants with fatigue received thrice-weekly sessions of dTMS for a duration of six weeks; this involves a stimulation H-coil being placed above the patient's head, which generates a magnetic field that influences nerve activity and neural circuits in the brain. A control group received a sham treatment.

"We observed no serious side effects in patients treated with dTMS, and it is therefore worth stressing the tolerability of this noninvasive electrophysiological technique," says Prof. Paul, the study's principal investigator. Further, it is also worth noting that the treatment was delivered using a new type of H-coil, which had been developed specifically for use in this study. This coil permits the targeted stimulation of areas of the brain which, according to the latest research, play a major role in MS-associated fatigue. A follow-up study involving a larger number of participants is being planned. This is intended to verify the efficacy of this treatment method, and to help ensure the implementation of dTMS for MS-associated fatigue into routine clinical practice. "We are excited about the collaboration between Prof. Dr. Friedemann Paul and his team at Charité's NeuroCure and Brainsway for studying the use of our patented Deep TMS technology for the benefit of MS patients, a new neurological field for us. These promising results of relieving the very hard to treat symptoms in MS, brings a new hope for being able to provide a solution for the many patients who need it." Says Ronen Segal, CTO of Brainsway LTD.

Explore further: Deep brain stimulation for the treatment of movement disorders

More information: Gunnar Gaede et al, Safety and preliminary efficacy of deep transcranial magnetic stimulation in MS-related fatigue, Neurology - Neuroimmunology Neuroinflammation (2017). DOI: 10.1212/nxi.0000000000000423

Related Stories

Deep brain stimulation for the treatment of movement disorders

December 27, 2017
For the first time, researchers from Charité have shown that in patients with a type of movement disorder known as dystonia, a particular pattern of brain activity is linked to both the severity of symptoms and the clinical ...

Transcranial direct current stimulation reduces fatigue associated with multiple sclerosis

October 2, 2017
People with multiple sclerosis (MS) who underwent a non-invasive form of electrical brain stimulation experienced significant reductions in fatigue, a common and often debilitating symptom of the disease, according to new ...

Magnetic brain stimulation causes weight loss by making gut bacteria healthier

April 3, 2017
A new study finds that a noninvasive electromagnetic brain stimulation technique helps obese people lose weight, partly by changing the composition of their intestinal bacteria—the so-called gut microbiota. Results of the ...

Anakinra ineffective for reducing symptoms of chronic fatigue

March 8, 2017
(HealthDay)—The anti-inflammatory biologic drug anakinra (Kineret) does not reduce fatigue severity in women with chronic fatigue syndrome, according to a study published online March 7 in the Annals of Internal Medicine.

How chronic fatigue syndrome wears patients out

July 28, 2017
(HealthDay)—Imagine if your muscles kept telling your brain you were exhausted, even when you were resting.

Multidisciplinary rehab tops CBT for chronic fatigue syndrome

August 31, 2015
(HealthDay)—For patients with chronic fatigue syndrome (CFS), multidisciplinary rehabilitation treatment (MRT) is more effective for reducing fatigue than cognitive behavioral therapy (CBT), according to a study published ...

Recommended for you

Do you see what I see? Researchers harness brain waves to reconstruct images of what we perceive

February 22, 2018
A new technique developed by neuroscientists at the University of Toronto Scarborough can, for the first time, reconstruct images of what people perceive based on their brain activity gathered by EEG.

Neuroscientists discover a brain signal that indicates whether speech has been understood

February 22, 2018
Neuroscientists from Trinity College Dublin and the University of Rochester have identified a specific brain signal associated with the conversion of speech into understanding. The signal is present when the listener has ...

Study in mice suggests personalized stem cell treatment may offer relief for multiple sclerosis

February 22, 2018
Scientists have shown in mice that skin cells re-programmed into brain stem cells, transplanted into the central nervous system, help reduce inflammation and may be able to help repair damage caused by multiple sclerosis ...

Biomarker, clues to possible therapy found in novel childhood neurogenetic disease

February 22, 2018
Researchers studying a rare genetic disorder that causes severe, progressive neurological problems in childhood have discovered insights into biological mechanisms that drive the disease, along with early clues that an amino ...

A look at the space between mouse brain cells

February 22, 2018
Between the brain's neurons and glial cells is a critical but understudied structure that's been called neuroscience's final frontier: the extracellular space. With a new imaging paradigm, scientists can now see into and ...

Nolan film 'Memento' reveals how the brain remembers and interprets events from clues

February 22, 2018
Key repeating moments in the film give viewers the information they need to understand the storyline. The scenes cause identical reactions in the viewer's brain. The results deepen our understanding of how the brain functions, ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

alex160113
not rated yet Feb 21, 2018
I have been diagnosed of multiple sclerosis (ms) for 6 years now, i have used so many prescriptions fromm my doctor but never gave me a cure rather controlling the symptoms, my symptoms where ( constipation, depression, difficulty swallowing, difficulty thinking and understanding, flare, headache, heavy legs, numbness of face etc.), my health and life was gradually deteriorating more and more, so i took a glance on the internet and i found (GENERAL HERBAL HEALTH CENTER) a HERBAL MEDICINE HOME that can cure multiple sclerosis (ms), i gave a test to their herbal product, i bought the medicine and it was shipped to my door step and in 9 weeks of usage i was cured totally.. thanks to general health center.
.
contact them today via email address: generalhealthcenter1@gmail.com .

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.